Huang, Haojie

FRA7G extends over a broad region: coincidence of human endogenous retroviral sequences (HERV-H) and small polydispersed circular DNAs (spcDNA) and fragile sites

Huang, H., Qian, J., Proffit, J., Wilber, K., Jenkins, R., & Smith, D. I. (1998) · Oncogene

Genomic variations and chromosomal abnormalitiesChromosomal and Genetic Variations

Cited by 72

A transcription-independent function of FOXO1 in inhibition of androgen-independent activation of the androgen receptor in prostate cancer cells.

Liu, P., Li, S., Gan, L., Kao, T. P., & Huang, H. (2008) · Cancer Research

Prostate Cancer Treatment and ResearchFOXO transcription factor regulation

Cited by 67

Dual inhibition of AKT-mTOR and AR signaling by targeting HDAC3 in PTEN- or SPOP-mutated prostate cancer

Yan, Y., An, J., Yang, Y., Wu, D., Bai, Y., Cao, W., Ma, L., Chen, J., Yu, Z., He, Y., et al. (2018) · EMBO Molecular Medicine

Prostate Cancer Treatment and ResearchHistone Deacetylase Inhibitors Research

Cited by 53

A novel highly potent trivalent TGF-β receptor trap inhibits early-stage tumorigenesis and tumor cell invasion in murine Pten-deficient prostate glands

Qin, T., Barron, L., Xia, L., Huang, H., Villarreal, M. M., Zwaagstra, J., Collins, C., Yang, J., Zwieb, C., Kodali, R., et al. (2016) · Oncotarget

TGF-β signaling in diseasesProstate Cancer Treatment and Research

Cited by 40

CDK2 and FOXO1: A Fork in the Road for Cell Fate Decisions

Huang, H., & Tindall, D. J. (2007) · Cell Cycle

FOXO transcription factor regulationCancer-related Molecular Pathways

Cited by 25

Destruction of DNA-binding proteins by programmable O’PROTAC: Oligonucleotide-based PROTAC

Shao, J., Yan, Y., Ding, D., Wang, D., He, Y., Pan, Y., Yan, W., Kharbanda, A., Li, H.-Y., & Huang, H. (2021) · bioRxiv (Cold Spring Harbor Laboratory)

Protein Degradation and InhibitorsChemical Synthesis and Analysis

Cited by 2